Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience.

Scala M, Fiaschi P, Capra V, Garrè ML, Tortora D, Ravegnani M, Pavanello M.

Childs Nerv Syst. 2018 Jul;34(7):1311-1323. doi: 10.1007/s00381-018-3833-7. Epub 2018 May 24. Review.

PMID:
29797062
2.

Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.

Mackay A, Burford A, Molinari V, Jones DTW, Izquierdo E, Brouwer-Visser J, Giangaspero F, Haberler C, Pietsch T, Jacques TS, Figarella-Branger D, Rodriguez D, Morgan PS, Raman P, Waanders AJ, Resnick AC, Massimino M, Garrè ML, Smith H, Capper D, Pfister SM, Würdinger T, Tam R, Garcia J, Thakur MD, Vassal G, Grill J, Jaspan T, Varlet P, Jones C.

Cancer Cell. 2018 May 14;33(5):829-842.e5. doi: 10.1016/j.ccell.2018.04.004.

3.

Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion.

Morana G, Tortora D, Staglianò S, Nozza P, Mascelli S, Severino M, Piatelli G, Consales A, Lequin M, Garrè ML, Rossi A.

Neuroradiology. 2018 Apr;60(4):437-446. doi: 10.1007/s00234-018-1992-6. Epub 2018 Feb 16.

PMID:
29453753
4.

ESCO1/2's roles in chromosome structure and interphase chromatin organization.

Kawasumi R, Abe T, Arakawa H, Garre M, Hirota K, Branzei D.

Genes Dev. 2017 Nov 1;31(21):2136-2150. doi: 10.1101/gad.306084.117. Epub 2017 Dec 1.

5.

T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study.

Morana G, Alves CA, Tortora D, Finlay JL, Severino M, Nozza P, Ravegnani M, Pavanello M, Milanaccio C, Maghnie M, Rossi A, Garrè ML.

Neuroradiology. 2018 Jan;60(1):89-99. doi: 10.1007/s00234-017-1947-3. Epub 2017 Nov 11.

PMID:
29128947
6.

Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.

Calaminus G, Frappaz D, Kortmann RD, Krefeld B, Saran F, Pietsch T, Vasiljevic A, Garre ML, Ricardi U, Mann JR, Göbel U, Alapetite C, Murray MJ, Nicholson JC.

Neuro Oncol. 2017 Nov 29;19(12):1661-1672. doi: 10.1093/neuonc/nox122.

PMID:
29048505
7.

Neuroendocrine late effects after tailored photon radiotherapy for children with low grade gliomas: Long term correlation with tumour and treatment parameters.

Aloi D, Belgioia L, Barra S, Giannelli F, Cavagnetto F, Gallo F, Milanaccio C, Garrè M, Di Profio S, Di Iorgi N, Corvò R.

Radiother Oncol. 2017 Nov;125(2):241-247. doi: 10.1016/j.radonc.2017.09.034. Epub 2017 Oct 13.

PMID:
29037775
8.

Added value of diffusion weighted imaging in pediatric central nervous system embryonal tumors surveillance.

Morana G, Alves CA, Tortora D, Severino M, Nozza P, Cama A, Ravegnani M, D'Apolito G, Raso A, Milanaccio C, da Costa Leite C, Garrè ML, Rossi A.

Oncotarget. 2017 Jul 25;8(36):60401-60413. doi: 10.18632/oncotarget.19553. eCollection 2017 Sep 1.

9.

Close congruence between Barcode Index Numbers (bins) and species boundaries in the Erebidae (Lepidoptera: Noctuoidea) of the Iberian Peninsula.

Ortiz AS, Rubio RM, Guerrero JJ, Garre MJ, Serrano J, Hebert PDN, Hausmann A.

Biodivers Data J. 2017 Aug 8;(5):e19840. doi: 10.3897/BDJ.5.e19840. eCollection 2017.

10.

Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.

Lassaletta A, Zapotocky M, Mistry M, Ramaswamy V, Honnorat M, Krishnatry R, Guerreiro Stucklin A, Zhukova N, Arnoldo A, Ryall S, Ling C, McKeown T, Loukides J, Cruz O, de Torres C, Ho CY, Packer RJ, Tatevossian R, Qaddoumi I, Harreld JH, Dalton JD, Mulcahy-Levy J, Foreman N, Karajannis MA, Wang S, Snuderl M, Nageswara Rao A, Giannini C, Kieran M, Ligon KL, Garre ML, Nozza P, Mascelli S, Raso A, Mueller S, Nicolaides T, Silva K, Perbet R, Vasiljevic A, Faure Conter C, Frappaz D, Leary S, Crane C, Chan A, Ng HK, Shi ZF, Mao Y, Finch E, Eisenstat D, Wilson B, Carret AS, Hauser P, Sumerauer D, Krskova L, Larouche V, Fleming A, Zelcer S, Jabado N, Rutka JT, Dirks P, Taylor MD, Chen S, Bartels U, Huang A, Ellison DW, Bouffet E, Hawkins C, Tabori U.

J Clin Oncol. 2017 Sep 1;35(25):2934-2941. doi: 10.1200/JCO.2016.71.8726. Epub 2017 Jul 20.

11.

Atypical choroid plexus papilloma: spontaneous resolution of diffuse leptomeningeal contrast enhancement after primary tumor removal in 2 pediatric cases.

Scala M, Morana G, Milanaccio C, Pavanello M, Nozza P, Garrè ML.

J Neurosurg Pediatr. 2017 Sep;20(3):284-288. doi: 10.3171/2017.2.PEDS16526. Epub 2017 Jul 7.

PMID:
28686125
12.

Childhood medulloblastoma.

Massimino M, Biassoni V, Gandola L, Garrè ML, Gatta G, Giangaspero F, Poggi G, Rutkowski S.

Crit Rev Oncol Hematol. 2016 Sep;105:35-51. doi: 10.1016/j.critrevonc.2016.05.012. Epub 2016 Jun 15. Review.

PMID:
27375228
13.

TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.

Mascelli S, Nozza P, Jones DT, Colin C, Pistorio A, Milanaccio C, Ravegnani M, Consales A, Witt O, Morana G, Cama A, Capra V, Biassoni R, Pfister SM, Figarella-Branger D, Garrè ML, Raso A.

Oncotarget. 2016 Jul 26;7(30):47918-47926. doi: 10.18632/oncotarget.10295.

14.

RAB2A controls MT1-MMP endocytic and E-cadherin polarized Golgi trafficking to promote invasive breast cancer programs.

Kajiho H, Kajiho Y, Frittoli E, Confalonieri S, Bertalot G, Viale G, Di Fiore PP, Oldani A, Garre M, Beznoussenko GV, Palamidessi A, Vecchi M, Chavrier P, Perez F, Scita G.

EMBO Rep. 2016 Jul;17(7):1061-80. doi: 10.15252/embr.201642032. Epub 2016 Jun 2.

15.

Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.

Massimino M, Miceli R, Giangaspero F, Boschetti L, Modena P, Antonelli M, Ferroli P, Bertin D, Pecori E, Valentini L, Biassoni V, Garrè ML, Schiavello E, Sardi I, Cama A, Viscardi E, Scarzello G, Scoccianti S, Mascarin M, Quaglietta L, Cinalli G, Diletto B, Genitori L, Peretta P, Mussano A, Buccoliero A, Calareso G, Barra S, Mastronuzzi A, Giussani C, Marras CE, Balter R, Bertolini P, Giombelli E, La Spina M, Buttarelli FR, Pollo B, Gandola L.

Neuro Oncol. 2016 Oct;18(10):1451-60. doi: 10.1093/neuonc/now108. Epub 2016 May 18.

16.

Pediatric craniospinal irradiation with conventional technique or helical tomotherapy: impact of age and body volume on integral dose.

Barra S, Gusinu M, Timon G, Giannelli F, Vidano G, Garrè ML, Corvò R.

Tumori. 2016 Aug 3;102(4):387-92. doi: 10.5301/tj.5000512. Epub 2016 Apr 7.

PMID:
27056336
17.

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.

Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AAN, Giannini C, Li KKW, Ng HK, Yao Y, Kumabe T, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DCY, Seow WT, Chang KTE, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, Fèvre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortobágyi T, Klekner A, László B, Pócza T, Hauser P, Schüller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen MC, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, López-Aguilar E, Lyden D, Garzia L, Shih DJH, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DTW, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V, Taylor MD.

Lancet Oncol. 2016 Apr;17(4):484-495. doi: 10.1016/S1470-2045(15)00581-1. Epub 2016 Mar 12.

18.

Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.

Morana G, Puntoni M, Garrè ML, Massollo M, Lopci E, Naseri M, Severino M, Tortora D, Rossi A, Piccardo A.

Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1664-72. doi: 10.1007/s00259-016-3333-5. Epub 2016 Feb 25.

PMID:
26911489
19.

18F-DOPA Uptake of Developmental Venous Anomalies in Children With Brain Tumors.

Morana G, Piccardo A, Garrè ML, Cabria M, Rossi A.

Clin Nucl Med. 2016 Jul;41(7):e351-2. doi: 10.1097/RLU.0000000000001189.

PMID:
26909711
20.

Divergent clonal selection dominates medulloblastoma at recurrence.

Morrissy AS, Garzia L, Shih DJ, Zuyderduyn S, Huang X, Skowron P, Remke M, Cavalli FM, Ramaswamy V, Lindsay PE, Jelveh S, Donovan LK, Wang X, Luu B, Zayne K, Li Y, Mayoh C, Thiessen N, Mercier E, Mungall KL, Ma Y, Tse K, Zeng T, Shumansky K, Roth AJ, Shah S, Farooq H, Kijima N, Holgado BL, Lee JJ, Matan-Lithwick S, Liu J, Mack SC, Manno A, Michealraj KA, Nor C, Peacock J, Qin L, Reimand J, Rolider A, Thompson YY, Wu X, Pugh T, Ally A, Bilenky M, Butterfield YS, Carlsen R, Cheng Y, Chuah E, Corbett RD, Dhalla N, He A, Lee D, Li HI, Long W, Mayo M, Plettner P, Qian JQ, Schein JE, Tam A, Wong T, Birol I, Zhao Y, Faria CC, Pimentel J, Nunes S, Shalaby T, Grotzer M, Pollack IF, Hamilton RL, Li XN, Bendel AE, Fults DW, Walter AW, Kumabe T, Tominaga T, Collins VP, Cho YJ, Hoffman C, Lyden D, Wisoff JH, Garvin JH Jr, Stearns DS, Massimi L, Schüller U, Sterba J, Zitterbart K, Puget S, Ayrault O, Dunn SE, Tirapelli DP, Carlotti CG, Wheeler H, Hallahan AR, Ingram W, MacDonald TJ, Olson JJ, Van Meir EG, Lee JY, Wang KC, Kim SK, Cho BK, Pietsch T, Fleischhack G, Tippelt S, Ra YS, Bailey S, Lindsey JC, Clifford SC, Eberhart CG, Cooper MK, Packer RJ, Massimino M, Garre ML, Bartels U, Tabori U, Hawkins CE, Dirks P, Bouffet E, Rutka JT, Wechsler-Reya RJ, Weiss WA, Collier LS, Dupuy AJ, Korshunov A, Jones DT, Kool M, Northcott PA, Pfister SM, Largaespada DA, Mungall AJ, Moore RA, Jabado N, Bader GD, Jones SJ, Malkin D, Marra MA, Taylor MD.

Nature. 2016 Jan 21;529(7586):351-7. doi: 10.1038/nature16478. Epub 2016 Jan 13.

21.

Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.

Morana G, Piccardo A, Puntoni M, Nozza P, Cama A, Raso A, Mascelli S, Massollo M, Milanaccio C, Garrè ML, Rossi A.

Neuro Oncol. 2015 Dec;17(12):1637-47. doi: 10.1093/neuonc/nov099. Epub 2015 Sep 23.

22.

New insights into central nervous system involvement in FOP: Case report and review of the literature.

Bertamino M, Severino M, Schiaffino MC, Garrè ML, Bocciardi R, Ravazzolo R, Rossi A, Di Rocco M.

Am J Med Genet A. 2015 Nov;167A(11):2817-21. doi: 10.1002/ajmg.a.37271. Epub 2015 Aug 4. Review.

PMID:
26239063
23.

Distinctive Genetic Profile With IDH1, TP53, and MLH1 Mutations in a Radiation-Induced Anaplastic Astrocytoma.

Mascelli S, Nozza P, Sak K, Joost K, Cama A, Capra V, Garrè ML, Raso A.

Pediatr Blood Cancer. 2016 Jan;63(1):179. doi: 10.1002/pbc.25671. Epub 2015 Jul 16. No abstract available.

PMID:
26185030
24.

Atypical teratoid/rhabdoid tumor (ATRT) arising from the 3rd cranial nerve in infants: a clinical-radiological entity?

Oh CC, Orr BA, Bernardi B, Garré ML, Rossi A, Figà-Talamanca L, Robinson GW, Patay Z.

J Neurooncol. 2015 Sep;124(2):175-83. doi: 10.1007/s11060-015-1787-0. Epub 2015 Jul 7.

25.

Late Persistent Increased Putaminal 18F-DOPA Uptake Following Ipsilateral Frontal Resection: Evidence for Corticostriatal Synaptic Plasticity?

Morana G, Piccardo A, Garrè ML, Nobili F, Rossi A.

Clin Nucl Med. 2015 Sep;40(9):e451-2. doi: 10.1097/RLU.0000000000000798.

PMID:
25899596
26.

Intradural Extramedullary Ependymoma with Leptomeningeal Dissemination: The First Case Report in a Child and Literature Review.

Severino M, Consales A, Doglio M, Tortora D, Morana G, Barra S, Nozza P, Garrè ML.

World Neurosurg. 2015 Sep;84(3):865.e13-9. doi: 10.1016/j.wneu.2015.04.002. Epub 2015 Apr 7.

PMID:
25862107
27.

Congenital multifocal rhabdoid tumor: a case with peculiar biological behavior and different response to treatment according to location (central nervous system and kidney).

Pio L, Milanaccio C, Mascelli S, Raso A, Nozza P, Sementa AR, Cama A, Buffa P, Avanzini S, Vannati M, Capra V, Lanino E, Rossi A, Morana G, Magnano GM, Severino M, Garrè ML.

Cancer Genet. 2014 Sep;207(9):441-4. doi: 10.1016/j.cancergen.2014.08.003. Epub 2014 Aug 24.

PMID:
25442925
28.

Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review.

Taramasso L, Boisson-Dupuis S, Garrè ML, Bondi E, Cama A, Nozza P, Morana G, Casanova JL, Marazzi MG.

J Clin Immunol. 2014 Nov;34(8):922-7. doi: 10.1007/s10875-014-0098-0. Epub 2014 Sep 14. Review.

PMID:
25216720
29.

The PAR complex controls the spatiotemporal dynamics of F-actin and the MTOC in directionally migrating leukocytes.

Crespo CL, Vernieri C, Keller PJ, Garrè M, Bender JR, Wittbrodt J, Pardi R.

J Cell Sci. 2014 Oct 15;127(Pt 20):4381-95. doi: 10.1242/jcs.146217. Epub 2014 Sep 1.

30.

Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019.

Vecchio D, Daga A, Carra E, Marubbi D, Raso A, Mascelli S, Nozza P, Garrè ML, Pitto F, Ravetti JL, Vagge S, Corvò R, Profumo A, Baio G, Marcello D, Frosina G.

Int J Cancer. 2015 Mar 15;136(6):1445-57. doi: 10.1002/ijc.29121. Epub 2014 Aug 11.

31.

ATR mediates a checkpoint at the nuclear envelope in response to mechanical stress.

Kumar A, Mazzanti M, Mistrik M, Kosar M, Beznoussenko GV, Mironov AA, Garrè M, Parazzoli D, Shivashankar GV, Scita G, Bartek J, Foiani M.

Cell. 2014 Jul 31;158(3):633-46. doi: 10.1016/j.cell.2014.05.046.

32.

A RAB5/RAB4 recycling circuitry induces a proteolytic invasive program and promotes tumor dissemination.

Frittoli E, Palamidessi A, Marighetti P, Confalonieri S, Bianchi F, Malinverno C, Mazzarol G, Viale G, Martin-Padura I, Garré M, Parazzoli D, Mattei V, Cortellino S, Bertalot G, Di Fiore PP, Scita G.

J Cell Biol. 2014 Jul 21;206(2):307-28. doi: 10.1083/jcb.201403127.

33.

Constitutional chromosomal events at 22q11 and 15q26 in a child with a pilocytic astrocytoma of the spinal cord.

Mascelli S, Severino M, Raso A, Nozza P, Tassano E, Morana G, De Marco P, Merello E, Milanaccio C, Pavanello M, Rossi A, Cama A, Garrè ML, Capra V.

Mol Cytogenet. 2014 May 15;7:31. doi: 10.1186/1755-8166-7-31. eCollection 2014.

34.

Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.

Morana G, Piccardo A, Milanaccio C, Puntoni M, Nozza P, Cama A, Zefiro D, Cabria M, Rossi A, Garrè ML.

J Nucl Med. 2014 May;55(5):718-23. doi: 10.2967/jnumed.113.125500. Epub 2014 Mar 20.

35.

Natural history of cavernous malformations in children with brain tumors treated with radiotherapy and chemotherapy.

Di Giannatale A, Morana G, Rossi A, Cama A, Bertoluzzo L, Barra S, Nozza P, Milanaccio C, Consales A, Garrè ML.

J Neurooncol. 2014 Apr;117(2):311-20. doi: 10.1007/s11060-014-1390-9. Epub 2014 Feb 11.

PMID:
24515423
36.

Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial.

Cefalo G, Massimino M, Ruggiero A, Barone G, Ridola V, Spreafico F, Potepan P, Abate ME, Mascarin M, Garrè ML, Perilongo G, Madon E, Colosimo C, Riccardi R.

Neuro Oncol. 2014 May;16(5):748-53. doi: 10.1093/neuonc/not320. Epub 2014 Jan 30.

37.

Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors.

Prato G, Mancardi MM, Baglietto MG, Janis S, Vercellino N, Rossi A, Consales A, Raso A, Garrè ML.

J Child Neurol. 2014 Sep;29(9):NP54-7. doi: 10.1177/0883073813499969. Epub 2013 Sep 20.

PMID:
24056156
38.

Molecular fingerprinting reflects different histotypes and brain region in low grade gliomas.

Mascelli S, Barla A, Raso A, Mosci S, Nozza P, Biassoni R, Morana G, Huber M, Mircean C, Fasulo D, Noy K, Wittemberg G, Pignatelli S, Piatelli G, Cama A, Garré ML, Capra V, Verri A.

BMC Cancer. 2013 Aug 15;13:387. doi: 10.1186/1471-2407-13-387.

39.

Diffuse leptomeningeal glioneuronal tumours: clinico-pathological follow-up.

Gardiman MP, Fassan M, Nozza P, Orvieto E, Garrè ML, Milanaccio C, Severino M, Perilongo G, Giangaspero F.

Pathologica. 2012 Dec;104(6):428-31.

PMID:
23547428
40.

Parental imbalances involving chromosomes 15q and 22q may predispose to the formation of de novo pathogenic microdeletions and microduplications in the offspring.

Capra V, Mascelli S, Garrè ML, Nozza P, Vaccari C, Bricco L, Sloan-Béna F, Gimelli S, Cuoco C, Gimelli G, Tassano E.

PLoS One. 2013;8(3):e57910. doi: 10.1371/journal.pone.0057910. Epub 2013 Mar 6.

41.
42.

A very rare cancer in Down syndrome: medulloblastoma. Epidemiological data from 13 countries.

Satgé D, Stiller CA, Rutkowski S, von Bueren AO, Lacour B, Sommelet D, Nishi M, Massimino M, Garré ML, Moreno F, Hasle H, Jakab Z, Greenberg M, von der Weid N, Kuehni C, Zurriaga O, Vicente ML, Peris-Bonet R, Benesch M, Vekemans M, Sullivan SG, Rickert C.

J Neurooncol. 2013 Mar;112(1):107-14. doi: 10.1007/s11060-012-1041-y. Epub 2013 Jan 11.

PMID:
23307327
43.
44.

Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysis.

Modena P, Buttarelli FR, Miceli R, Piccinin E, Baldi C, Antonelli M, Morra I, Lauriola L, Di Rocco C, Garrè ML, Sardi I, Genitori L, Maestro R, Gandola L, Facchinetti F, Collini P, Sozzi G, Giangaspero F, Massimino M.

Neuro Oncol. 2012 Nov;14(11):1346-56. doi: 10.1093/neuonc/nos245. Epub 2012 Oct 17.

45.

Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: report of a secondary anaplastic astrocytoma carrying the IDH1 mutation.

Mascelli S, Raso A, Biassoni R, Severino M, Sak K, Joost K, Milanaccio C, Barra S, Grillo-Ruggieri F, Vanni I, Consales A, Cama A, Capra V, Nozza P, Garrè ML.

J Neurooncol. 2012 Sep;109(3):477-84. doi: 10.1007/s11060-012-0925-1. Epub 2012 Jul 22.

PMID:
22821382
46.

Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance.

Antonelli M, Massimino M, Morra I, Garrè ML, Gardiman MP, Buttarelli FR, Arcella A, Giangaspero F.

Neuropathology. 2012 Apr;32(2):133-8. doi: 10.1111/j.1440-1789.2011.01252.x. Epub 2011 Oct 6.

PMID:
21978279
47.

Epidemiology of febrile neutropenia in children with central nervous system tumor: results from a single center prospective study.

Castagnola E, Garrè ML, Bertoluzzo L, Pignatelli S, Pavanello M, Caviglia I, Caruso S, Bagnasco F, Moroni C, Tacchella A, Haupt R.

J Pediatr Hematol Oncol. 2011 Oct;33(7):e310-5. doi: 10.1097/MPH.0b013e31822bf6ec.

PMID:
21941135
48.

Second-look surgery for ependymoma: the Italian experience.

Massimino M, Solero CL, Garrè ML, Biassoni V, Cama A, Genitori L, Di Rocco C, Sardi I, Viscardi E, Modena P, Potepan P, Barra S, Scarzello G, Galassi E, Giangaspero F, Antonelli M, Gandola L.

J Neurosurg Pediatr. 2011 Sep;8(3):246-50. doi: 10.3171/2011.6.PEDS1142.

PMID:
21882914
49.

Streptococcus australis meningitis.

Héry-Arnaud G, Rouzic N, Doloy A, Le Lay G, Garré M, Payan C, Poyart C.

J Med Microbiol. 2011 Nov;60(Pt 11):1701-4. doi: 10.1099/jmm.0.030114-0. Epub 2011 Jul 7.

PMID:
21737544
50.

Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.

Pezzolo A, Coco S, Raso A, Parodi F, Pistorio A, Valdora F, Capra V, Zollo M, Aschero S, Basso E, Cama A, Nozza P, Gambini C, Cinalli G, Garrè ML, Iolascon A, Pistoia V, Tonini GP.

Cancer Lett. 2011 Sep 28;308(2):215-24. doi: 10.1016/j.canlet.2011.05.006. Epub 2011 Jun 8.

PMID:
21652146

Supplemental Content

Support Center